drugset / Trial / NCT02111044
Phase II Study With ITF2984 in Acromegalic Patients
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to investigate in acromegalic patients the effect of different doses of ITF2984 on GH and IGF-1 concentrations and to investigate safety and tolerability of three different doses of ITF2984.
Timeline
- Start
- 2014-04
- Primary completion
- 2016-02
- Completion
- 2016-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ITF2984 | Other / unclassified | 500 ug | Subcutaneous |
| Subject | ITF2984 | Other / unclassified | 1000 ug | Subcutaneous |
| Subject | ITF2984 | Other / unclassified | 2000 ug | Subcutaneous |
| Comparator | Octreotide | Peptide | 100 ug | Subcutaneous |